Granules India Limited
Granules India Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: GRANULES and BSE: 532482 (ISIN INE101D01020).
It has a market capitalisation of ₹19,974 crore, a last close of ₹806.05 on 2026-10-19, a one-year return of 41.5%.
Valuation: a price-to-earnings ratio of 30.16x, a price-to-book ratio of 3.93x, a dividend yield of 0.2%.
Profitability: return on equity of 13.5%, return on capital employed of 18.2%, an operating margin of 22.7%.
Growth: sales growth of 5.9% a year over three years, net profit growth of 4.8% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.26x, promoter holding of 37.4%.
| Metric | Value |
|---|---|
| Market capitalisation | 19,974 |
| Last close | ₹806.05 |
| P/E (TTM) | 30.16x |
| P/B | 3.93x |
| Dividend yield | 0.2% |
| ROE (FY) | 13.5% |
| ROCE (FY) | 18.2% |
| Operating margin (TTM) | 22.7% |
| Sales growth, 3-year CAGR | 5.9% |
| Profit growth, 3-year CAGR | 4.8% |
| Debt / equity | 0.26x |
| Promoter holding | 37.4% |
| 1-year return | 41.5% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means